Offensive marketing strategies for switched non-prescription drugs eyed

Published: 2002-05-07 06:58:00

Updated: 2002-05-07 06:58:00

Pharmaceutical industry sources say that the domestic drugs makers of digestives and antacids are intensifying their countermeasure strategies in marketing to minimize the impacts associated with the government's policy which switched more than 900 OTC drugs, including digestives and antacids, in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK